Dark | Light
[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]

# ![Karuna Therapeutics, Inc. Common Stock Graphic](https://lunarcrush.com/gi/w:26/t:$krtx.png) Karuna Therapeutics, Inc. Common Stock (KRTX)

KRTX hits a 1-year high, but low social buzz sparks price correction concerns. Insider selling is noted, but the stock may still be acquired, according to recent reports.

### About Karuna Therapeutics, Inc. Common Stock
Karuna Therapeutics, Inc. Common Stock (KRTX) is a stock in the healthcare sector.  
Karuna Therapeutics, Inc. Common Stock uses the ticker $KRTX for trading. Listed in the [Stocks](/list/stocks) and  category within the [Healthcare](/list/stocks/healthcare) sectors.

### Insights [#](/topic/$krtx/insights)
- Karuna Therapeutics, Inc. Common Stock (KRTX) market dominance near a 52-week low at XXXXX.
- Karuna Therapeutics, Inc. Common Stock (KRTX) social dominance is up XXXXX% from the previous week.
- Karuna Therapeutics, Inc. Common Stock (KRTX) galaxy score™ is up XX% from the previous week.

### Price: $XXXXXX [#](/topic/$krtx/close)
---
![Price Line Chart](https://lunarcrush.com/gi/w:600/t:$krtx/c:line/m:close/iv:1d.svg)  
[Price 24-Hour Time-Series Raw Data](/topic/$krtx/time-series/close.tsv)  
The stock is at a 1-year high, but the lack of substantial social engagement suggests a potential price correction. Insider selling is noted, but the stock may still be acquired.  

**1-Year High**: $XXXXXX on 2024-10-20  
**1-Year Low**: $XXXXXX on 2024-10-20  
  
  
### AltRank: XXXXX [#](/topic/$krtx/alt_rank)
---
![AltRank Line Chart](https://lunarcrush.com/gi/w:600/t:$krtx/c:line/m:alt_rank/iv:1d.svg)  
[AltRank 24-Hour Time-Series Raw Data](/topic/$krtx/time-series/alt_rank.tsv)  
Karuna Therapeutics, Inc. Common Stock (KRTX) is currently AltRank #1,618 based on combined combined social and market metrics
**Daily Average**: XXXXX  
**1 Week**: XXXXX +354  
**1 Month**: XXXXX +881  
**6 Months**: XXXXX -XXX  
**1 Year**: XXXXX +119  
**1-Year High**: XXXXX on 2025-08-23  
**1-Year Low**: XXX on 2025-04-05  
  
  
### Galaxy Score: XXXXX [#](/topic/$krtx/galaxy_score)
---
![Galaxy Score Line Chart](https://lunarcrush.com/gi/w:600/t:$krtx/c:line/m:galaxy_score/iv:1d.svg)  
[Galaxy Score 24-Hour Time-Series Raw Data](/topic/$krtx/time-series/galaxy_score.tsv)  
**Current Value**: XXXXX  
**Daily Average**: XX  
**1 Week**: XX +12  
**1 Month**: XX +11  
**6 Months**: XX +1  
**1 Year**: XX -XX  
**1-Year High**: XX on 2025-03-03  
**1-Year Low**: XX on 2024-10-26  
  
  
### Engagements: XXX [#](/topic/$krtx/interactions)
---
![Engagements Line Chart](https://lunarcrush.com/gi/w:600/t:$krtx/c:line/m:interactions/iv:1d.svg)  
[Engagements 24-Hour Time-Series Raw Data](/topic/$krtx/time-series/interactions.tsv)  
**Current Value**: XXX  
**Daily Average**: XXXXX  
**1 Week**: XXXXX -XX%  
**1 Month**: XXXXXX -XX%  
**6 Months**: XXXXXXX -XX%  
**1 Year**: XXXXXXXXX -XX%  
**1-Year High**: XXXXXX on 2024-11-12  
**1-Year Low**: XX on 2024-12-03  

| Social Network | X   |
| -------------- | -   |
| Engagements    | XXX |
  

  
  
### Mentions: X [#](/topic/$krtx/posts_active)
---
![Mentions Line Chart](https://lunarcrush.com/gi/w:600/t:$krtx/c:line/m:posts_active/iv:1d.svg)  
[Mentions 24-Hour Time-Series Raw Data](/topic/$krtx/time-series/posts_active.tsv)  
**Current Value**: X  
**Daily Average**: XX  
**1 Month**: XX -XX%  
**6 Months**: XXX -XX%  
**1 Year**: XXX -XX%  
**1-Year High**: XXX on 2024-10-22  
**1-Year Low**: X on 2025-03-28  

| Social Network | X  |
| -------------- | -  |
| Mentions       | XX |
  

  
  
### Creators: X [#](/topic/$krtx/contributors_active)
---
![Creators Line Chart](https://lunarcrush.com/gi/w:600/t:$krtx/c:line/m:contributors_active/iv:1d.svg)  
[Creators 24-Hour Time-Series Raw Data](/topic/$krtx/time-series/contributors_active.tsv)  
X unique social accounts have posts mentioning Karuna Therapeutics, Inc. Common Stock (KRTX) in the last XX hours which is no change from in the previous XX hours
**Daily Average**: XX  
**1 Month**: XX -XX%  
**6 Months**: XXX -XX%  
**1 Year**: XXX -XX%  
**1-Year High**: XXX on 2024-10-22  
**1-Year Low**: X on 2024-10-20  

The most influential creators that mention Karuna Therapeutics, Inc. Common Stock in the last XX hours

| Creator                                    | Rank | Followers | Posts | Engagements |
| -------                                    | ---- | --------- | ----- | ----------- |
| [@Biobeats99](/creator/twitter/Biobeats99) | X    | XXX       | X     | XX          |

[View More](/list/creators/$krtx/100)
  
  
### Sentiment: XXX% [#](/topic/$krtx/sentiment)
---
![Sentiment Line Chart](https://lunarcrush.com/gi/w:600/t:$krtx/c:line/m:sentiment/iv:1d.svg)  
[Sentiment 24-Hour Time-Series Raw Data](/topic/$krtx/time-series/sentiment.tsv)  
**Current Value**: XXX%  
**Daily Average**: XX%  
**1 Week**: XXX% no change  
**1 Month**: XXX% no change  
**6 Months**: XXX% no change  
**1 Year**: XXX% no change  
**1-Year High**: XXX% on 2024-10-20  
**1-Year Low**: XX% on 2025-04-23  

**Most Supportive Themes**
- **Potential for Acquisition:** (30%) The stock may still be acquired, as noted in the provided context.
- **Mentions of other stocks:** (20%) Mentions of other stocks in the same sector are supportive of the stock.
  
**Most Critical Themes**
- **Low Social Buzz:** (50%)  The lack of substantial social engagement suggests a potential price correction.
  
Network engagement breakdown:  
| Network | Positive | %   | Neutral | %  | Negative | %  |
| ------- | -------- | -   | ------- | -  | -------- | -  |
| X       | XXX      | XX% | XX      | X% | X        | X% |
|         |          |     |         |    |          |    |
| Total   | XXX      | XX% | XX      | X% | X        | X% |
  

  
  
### Social Dominance: XXXXXXX% [#](/topic/$krtx/social_dominance)
---
![Social Dominance Line Chart](https://lunarcrush.com/gi/w:600/t:$krtx/c:line/m:social_dominance/iv:1d.svg)  
[Social Dominance 24-Hour Time-Series Raw Data](/topic/$krtx/time-series/social_dominance.tsv)  
**Current Value**: XXXXXXX%  
**Daily Average**: XXXXXXX%  
**1 Week**: XXXXXX% +0.00010000000000000005%  
**1 Month**: XXXXXX% -XXXXXX%  
**6 Months**: XXXXXX% -XXXXXX%  
**1 Year**: XXXXXX% -XXXXXX%  
**1-Year High**: XXXXX% on 2024-10-22  
**1-Year Low**: XXXXXX% on 2025-10-19  
  
  
### Market Dominance: XXXXX% [#](/topic/$krtx/market_dominance)
---
![Market Dominance Line Chart](https://lunarcrush.com/gi/w:600/t:$krtx/c:line/m:market_dominance/iv:1d.svg)  
[Market Dominance 24-Hour Time-Series Raw Data](/topic/$krtx/time-series/market_dominance.tsv)  
**Current Value**: XXXXX%  
**Daily Average**: X%  
**1-Year High**: XXXX% on 2025-04-08  
**1-Year Low**: XXXXX% on 2025-10-08  

**Top assets mentioned**
In the posts about Karuna Therapeutics, Inc. Common Stock in the last XX hours

[Acadia Pharmaceuticals Inc. (ACAD)](/topic/$acad)
[Cytokinetics Inc. (CYTK)](/topic/$cytk)
[Cere Network (CERE)](/topic/cere-network)
[Elanco Animal Health Incorporated Common Stock (ELAN)](/topic/$elan)
[CRISPR Therapeutics AG (CRSP)](/topic/$crsp)
[Sage Therapeutics, Inc (SAGE)](/topic/$sage)
[Inari Medical, Inc. Common Stock (NARI)](/topic/$nari)
[Blueprint Medicines Corporation (BPMC)](/topic/$bpmc)
[Immunogen Inc (IMGN)](/topic/$imgn)

**Top topics mentioned**
In the posts about Karuna Therapeutics, Inc. Common Stock in the last XX hours

[coins defi](/topic/coins-defi), [stocks healthcare](/topic/stocks-healthcare), [coins made in usa](/topic/coins-made-in-usa), [$acad](/topic/$acad), [$cytk](/topic/$cytk), [cere network](/topic/cere-network), [coins dao](/topic/coins-dao), [$elan](/topic/$elan), [$crsp](/topic/$crsp), [coins depin](/topic/coins-depin), [investment](/topic/investment), [telegram](/topic/telegram), [$sage](/topic/$sage), [$nari](/topic/$nari), [$bpmc](/topic/$bpmc), [$myov](/topic/$myov), [$imgn](/topic/$imgn), [$vktx](/topic/$vktx), [$xene](/topic/$xene), [$exel](/topic/$exel), [regeneron pharmaceuticals inc](/topic/regeneron-pharmaceuticals-inc), [$bmrn](/topic/$bmrn), [coins base ecosystem](/topic/coins-base-ecosystem), [$blue](/topic/$blue), [$alks](/topic/$alks), [$qure](/topic/$qure), [$bmy](/topic/$bmy), [$myok](/topic/$myok), [$nmra](/topic/$nmra), [coins dot](/topic/coins-dot), [$skye](/topic/$skye), [$prgo](/topic/$prgo), [$etnb](/topic/$etnb), [$trda](/topic/$trda), [$axsm](/topic/$axsm), [bank of america](/topic/bank-of-america), [united states](/topic/united-states)

### Top Social Posts [#](/topic/$krtx/posts)
---
Top posts by engagements in the last XX hours

*Showing only X posts for non-authenticated requests. Use your API key in requests for full results.*

"Monster in the making $CRSP $PRGO $OGN $ELAN $ZTS $ROIV $BHC $MYL $AMRX $CORT $IRWD $SUPN $LGND $PCRX $KRTX $ACAD $ARVN $BLUE $AGIO $FOLD $SAGE $XENE $PTCT $VNDA $ZGNX $AERI $ANAB $AVIR $BPMC $CLVS $DCPH $EBS $ENDP $EPZM $ESPR $GERN $GWPH $HRTX $INVA"  
[X Link](https://x.com/mariostario2019/status/1978135556371444180) [@mariostario2019](/creator/x/mariostario2019) 2025-10-14T16:27Z XX followers, XXX engagements


"$BMY patent cliff is a huge problem for the company. Expensive acquisitions $KRTX $MYOK (Camzyos sales accelerating but $CYTK might have the better drug) $MRTX $RYZB and $CELG in the past. BMS needs commercial drug assets imo. $MDGL $BBIO $AXSM $NBIX $TLX"  
[X Link](https://x.com/doepke_michel/status/1977369129972650327) [@doepke_michel](/creator/x/doepke_michel) 2025-10-12T13:41Z 5621 followers, 8253 engagements


"LT position updates: Part X XX Portfolio Pick Buyouts $NARI $BPMC $MYOV $IMGN $KRTX $HZNP $PRVB $ISEE $BLU $CTIC $FSTX $ICVX $LVGO $STML $JUNO $CMRX $RLYP Tech positions- $TSLA $SOFI $COIN $GOOG $AMZN $NVDA $TTD $IREN $NBIS $DUOL $HOOD $ASTS $RKLB $BMNR $META Bio positions: $VKTX $TMDX $MDGL $CYTK $CELC $QURE $DAWN $SRPT $AXSM $TGTX $LLY $OCUL $OSCR $RNA $HROW $PEPG $SLNO $KVUE"  
[X Link](https://x.com/Pharmdca/status/1975769719270744208) [@Pharmdca](/creator/x/Pharmdca) 2025-10-08T03:46Z 109K followers, 29.5K engagements


"Bank of America AMLX US: Amylyx Pharmaceuticals: Price Objective Change - Capital raise improves cash runway ahead of pipeline updates PO to $XX - BUY - United States Full report in Telegram (in bio)☝ (Tickers: $AMLX $SAGE $ACAD $NBIX $KRTX $CYTK)"  
[X Link](https://x.com/Biobeats99/status/1974436546939130125) [@Biobeats99](/creator/x/Biobeats99) 2025-10-04T11:28Z XXX followers, XXX engagements

[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]

Karuna Therapeutics, Inc. Common Stock Graphic Karuna Therapeutics, Inc. Common Stock (KRTX)

KRTX hits a 1-year high, but low social buzz sparks price correction concerns. Insider selling is noted, but the stock may still be acquired, according to recent reports.

About Karuna Therapeutics, Inc. Common Stock

Karuna Therapeutics, Inc. Common Stock (KRTX) is a stock in the healthcare sector.
Karuna Therapeutics, Inc. Common Stock uses the ticker $KRTX for trading. Listed in the Stocks and category within the Healthcare sectors.

Insights #

  • Karuna Therapeutics, Inc. Common Stock (KRTX) market dominance near a 52-week low at XXXXX.
  • Karuna Therapeutics, Inc. Common Stock (KRTX) social dominance is up XXXXX% from the previous week.
  • Karuna Therapeutics, Inc. Common Stock (KRTX) galaxy score™ is up XX% from the previous week.

Price: $XXXXXX #

Price Line Chart
Price 24-Hour Time-Series Raw Data
The stock is at a 1-year high, but the lack of substantial social engagement suggests a potential price correction. Insider selling is noted, but the stock may still be acquired.

1-Year High: $XXXXXX on 2024-10-20
1-Year Low: $XXXXXX on 2024-10-20

AltRank: XXXXX #

AltRank Line Chart
AltRank 24-Hour Time-Series Raw Data
Karuna Therapeutics, Inc. Common Stock (KRTX) is currently AltRank #1,618 based on combined combined social and market metrics Daily Average: XXXXX
1 Week: XXXXX +354
1 Month: XXXXX +881
6 Months: XXXXX -XXX
1 Year: XXXXX +119
1-Year High: XXXXX on 2025-08-23
1-Year Low: XXX on 2025-04-05

Galaxy Score: XXXXX #

Galaxy Score Line Chart
Galaxy Score 24-Hour Time-Series Raw Data
Current Value: XXXXX
Daily Average: XX
1 Week: XX +12
1 Month: XX +11
6 Months: XX +1
1 Year: XX -XX
1-Year High: XX on 2025-03-03
1-Year Low: XX on 2024-10-26

Engagements: XXX #

Engagements Line Chart
Engagements 24-Hour Time-Series Raw Data
Current Value: XXX
Daily Average: XXXXX
1 Week: XXXXX -XX%
1 Month: XXXXXX -XX%
6 Months: XXXXXXX -XX%
1 Year: XXXXXXXXX -XX%
1-Year High: XXXXXX on 2024-11-12
1-Year Low: XX on 2024-12-03

Social Network X
Engagements XXX

Mentions: X #

Mentions Line Chart
Mentions 24-Hour Time-Series Raw Data
Current Value: X
Daily Average: XX
1 Month: XX -XX%
6 Months: XXX -XX%
1 Year: XXX -XX%
1-Year High: XXX on 2024-10-22
1-Year Low: X on 2025-03-28

Social Network X
Mentions XX

Creators: X #

Creators Line Chart
Creators 24-Hour Time-Series Raw Data
X unique social accounts have posts mentioning Karuna Therapeutics, Inc. Common Stock (KRTX) in the last XX hours which is no change from in the previous XX hours Daily Average: XX
1 Month: XX -XX%
6 Months: XXX -XX%
1 Year: XXX -XX%
1-Year High: XXX on 2024-10-22
1-Year Low: X on 2024-10-20

The most influential creators that mention Karuna Therapeutics, Inc. Common Stock in the last XX hours

Creator Rank Followers Posts Engagements
@Biobeats99 X XXX X XX

View More

Sentiment: XXX% #

Sentiment Line Chart
Sentiment 24-Hour Time-Series Raw Data
Current Value: XXX%
Daily Average: XX%
1 Week: XXX% no change
1 Month: XXX% no change
6 Months: XXX% no change
1 Year: XXX% no change
1-Year High: XXX% on 2024-10-20
1-Year Low: XX% on 2025-04-23

Most Supportive Themes

  • Potential for Acquisition: (30%) The stock may still be acquired, as noted in the provided context.
  • Mentions of other stocks: (20%) Mentions of other stocks in the same sector are supportive of the stock.

Most Critical Themes

  • Low Social Buzz: (50%) The lack of substantial social engagement suggests a potential price correction.

Network engagement breakdown:

Network Positive % Neutral % Negative %
X XXX XX% XX X% X X%
Total XXX XX% XX X% X X%

Social Dominance: XXXXXXX% #

Social Dominance Line Chart
Social Dominance 24-Hour Time-Series Raw Data
Current Value: XXXXXXX%
Daily Average: XXXXXXX%
1 Week: XXXXXX% +0.00010000000000000005%
1 Month: XXXXXX% -XXXXXX%
6 Months: XXXXXX% -XXXXXX%
1 Year: XXXXXX% -XXXXXX%
1-Year High: XXXXX% on 2024-10-22
1-Year Low: XXXXXX% on 2025-10-19

Market Dominance: XXXXX% #

Market Dominance Line Chart
Market Dominance 24-Hour Time-Series Raw Data
Current Value: XXXXX%
Daily Average: X%
1-Year High: XXXX% on 2025-04-08
1-Year Low: XXXXX% on 2025-10-08

Top assets mentioned In the posts about Karuna Therapeutics, Inc. Common Stock in the last XX hours

Acadia Pharmaceuticals Inc. (ACAD) Cytokinetics Inc. (CYTK) Cere Network (CERE) Elanco Animal Health Incorporated Common Stock (ELAN) CRISPR Therapeutics AG (CRSP) Sage Therapeutics, Inc (SAGE) Inari Medical, Inc. Common Stock (NARI) Blueprint Medicines Corporation (BPMC) Immunogen Inc (IMGN)

Top topics mentioned In the posts about Karuna Therapeutics, Inc. Common Stock in the last XX hours

coins defi, stocks healthcare, coins made in usa, $acad, $cytk, cere network, coins dao, $elan, $crsp, coins depin, investment, telegram, $sage, $nari, $bpmc, $myov, $imgn, $vktx, $xene, $exel, regeneron pharmaceuticals inc, $bmrn, coins base ecosystem, $blue, $alks, $qure, $bmy, $myok, $nmra, coins dot, $skye, $prgo, $etnb, $trda, $axsm, bank of america, united states

Top Social Posts #

Top posts by engagements in the last XX hours

Showing only X posts for non-authenticated requests. Use your API key in requests for full results.

"Monster in the making $CRSP $PRGO $OGN $ELAN $ZTS $ROIV $BHC $MYL $AMRX $CORT $IRWD $SUPN $LGND $PCRX $KRTX $ACAD $ARVN $BLUE $AGIO $FOLD $SAGE $XENE $PTCT $VNDA $ZGNX $AERI $ANAB $AVIR $BPMC $CLVS $DCPH $EBS $ENDP $EPZM $ESPR $GERN $GWPH $HRTX $INVA"
X Link @mariostario2019 2025-10-14T16:27Z XX followers, XXX engagements

"$BMY patent cliff is a huge problem for the company. Expensive acquisitions $KRTX $MYOK (Camzyos sales accelerating but $CYTK might have the better drug) $MRTX $RYZB and $CELG in the past. BMS needs commercial drug assets imo. $MDGL $BBIO $AXSM $NBIX $TLX"
X Link @doepke_michel 2025-10-12T13:41Z 5621 followers, 8253 engagements

"LT position updates: Part X XX Portfolio Pick Buyouts $NARI $BPMC $MYOV $IMGN $KRTX $HZNP $PRVB $ISEE $BLU $CTIC $FSTX $ICVX $LVGO $STML $JUNO $CMRX $RLYP Tech positions- $TSLA $SOFI $COIN $GOOG $AMZN $NVDA $TTD $IREN $NBIS $DUOL $HOOD $ASTS $RKLB $BMNR $META Bio positions: $VKTX $TMDX $MDGL $CYTK $CELC $QURE $DAWN $SRPT $AXSM $TGTX $LLY $OCUL $OSCR $RNA $HROW $PEPG $SLNO $KVUE"
X Link @Pharmdca 2025-10-08T03:46Z 109K followers, 29.5K engagements

"Bank of America AMLX US: Amylyx Pharmaceuticals: Price Objective Change - Capital raise improves cash runway ahead of pipeline updates PO to $XX - BUY - United States Full report in Telegram (in bio)☝ (Tickers: $AMLX $SAGE $ACAD $NBIX $KRTX $CYTK)"
X Link @Biobeats99 2025-10-04T11:28Z XXX followers, XXX engagements

Karuna Therapeutics, Inc. Common Stock (KRTX)
/topic/$krtx